# Ezetimibe and Simvastatin

NDC: 43598-745
Generic name: Ezetimibe and Simvastatin
Labeler / Manufacturer: Dr.Reddys Laboratories Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20181120
Marketing ended: 20261130
FDA application: ANDA200909

## Active ingredients

- EZETIMIBE: 10 mg/1
- SIMVASTATIN: 80 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43598-745"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43598-745
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=023ca87a-1b04-8c17-dc4f-e2758b0771e2